The United Kingdom’s pharmaceutical sector stands as one of the most critical components of its economy and healthcare infrastructure. With a legacy of scientific innovation, robust academic-industry collaboration, and a well-established regulatory environment, the UK has long been a global leader in pharmaceuticals. However, the recent global disruptions—from Brexit to the COVID-19 pandemic—have underscored the […]